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Effect of antibody charge and concentration on deposition of antibody
to glomerular basement membrane. Fixed anionic sites within the
glomerular capillary wall influence the permeation of serum proteins,
the localization of various antigens, and the deposition of antibody in
the subepithelial space. In anti-GBM nephritis antibody deposition
occurs very rapidly to antigenic sites located relatively proximal in the
glomerular capillary wall. We examined the influence of the glomerular
charge barrier on anti-GBM antibody deposition by comparing the rate
of deposition of antibodies with cationic and anionic isoelectric points.
Purified sheep anti-rat GBM IgG was isolated from acid eluates of
kidneys obtained 24 hr after rats were injected with sheep antiserum to
rat GBM. Anti-GBM IgU was separated into cationic (p1 6.4—8.5) and
anionic (p1 4.2—6.8) fractions, which were radiolabelled with 131j and
1251, respectively, shown to have equal antibody contents measured by
in vitro binding to normal glomeruli, mixed in equal amounts, and
injected in incremental doses to ten rats. At 1 hr the glomerular
antibody binding of each fraction was directly related to the blood level(r = 0.95, r = 0.97) and delivery of antibody (r = 0.98, r = 0.98).
Glomerular binding of cationic antibody was four times greater than
anionic antibody over the entire range of deliveries studied (P < 0.001).
We conclude that glomerular deposition of anti-GBM antibody is
directly related to blood concentration and delivery of antibody.
Furthermore, the deposition of cationic antibodies to GBM antigens
was significantly greater than the deposition of anionic antibodies. The
charge-selective glomerular filtration barrier may be an important
determinant of the quantity and subclass composition of anti-GBM lgG
deposits in glomeruli, and therefore of the severity of tissue injury
produced.
Effet de Ia charge et de Ia concentration d'un anticorps sur le dépôt
d'anticorps sur Ia membrane basale glomerulaire. Les sites anioniques
fixes dans Ia paroi capillaire glomërulaire influencent le passage des
protéines sériques, Ia localisation de divers antigènes et le dépôt
d'anticorps dans l'espace sousépithélial. Dans Ia néphrite a anti-GBM,
le depot d'anticorps survient très rapidement sur des sites antigéniques
situés de facon relativement proximate dans la paroi capillaire
glomerulaire. Nous avons examine l'influence de Ia barrière de charge
glomerulaire sur de depot d'anticorps anti-GBM en comparant la
vitesse de depot d'anticorps avec des points isoélectriques cationiques
ou anioniques. De l'IgG purifiée de mouton anti-GBM de rat a Cté isolée
a partir d'éluats acides de reins obtenus 24 heures aprés que les rats
aient recu des injections d'antisérum de mouton contre Ia GBM de rat.
Les lgG anti-GBM ont été séparées en fractions cationiques (p1 6,4—8,5)
et anioniques (p1 4,2—6,8) qui ont été radiomarquees avec 1311 et 1251,
respectivement, dont on a montré que le contenu anticorps était
identique en le mesurant par leur liaison in vitro a des glomerules
normaux, qui ont été mélanges en quantités egales et injectCs a des
doses croissantes a dix rats. Au bout d'une heure, La liaison
glomerulaire de chaque fraction d'anticorps était directement liée a leur
niveau sanguin (r 0,95, r = 0,97), et a l'afflux d'anticorps (r = 0,98,
r = 0,98). La liaison glomerulaire d'anticorps cationiques Ctait quatre
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fois plus grande que celle des anticorps anioniques pour l'ensemble des
afflux étudiés (P < 0,001). Nous concluons que le depot glomérulaire
d'anticorps anti-GBM est directement relié a Ia concentration sanguine
et a l'afflux de l'anticorps. En outre, le depOt d'anticorps cationiques
sur les antigènes GBM était significativement plus élevé que Ic depOt
des anticorps anioniques. La barrière de filtration glomerulaire liée aux
charges pourrait être un determinant important de La quantité et de Ia
composition des sous-classes des depOts d'IgG anti-GBM dans les
glomerules et donc de la sévérité de Ia lesion tissulaire provoquée.
It is now well established that the normal glomerular capillary
wall is a highly negatively charged structure with the negative
charges conferred largely by the sialoglycoprotein coating on
glomerular epithelial and endothelial cells [1—71, and the poly-
anionic heparan-sulfate containing glycosaminoglycans within
the lamina rara externa and interna [8, 9]. Several studies have
documented the importance of this negative charge barrier in
regulating the glomerular filtration of variously charged dextran
polymers [10—12] and proteins [13, 14]. Recently, glomerular
charge properties have also been implicated in the development
of immune glomerular injury, primarily by facilitating localiza-
tion of various cationic antigens along the capillary wall where
they then initiate in situ immune complex formation [15—17].
Neutralization of the charge barrier has been shown to reduce
glomerular immune deposit formation due to cationic antigens
[18, 19] and to increase deposits formed with anionic antigens
[201.
We reasoned that negatively charged components of the
glomerular capillary wall might also influence glomerular locali-
zation of antibodies of differing charge. Different subclasses of
IgG are characterized by different isoelectric points as well as
by substantial differences in biological properties such as
plasma half-life, cryoprecipitation, and complement fixation
[21, 22]. Because all of these processes may contribute to tissue
injury, the selective deposition of antibodies of different
subclasses based on charge might significantly affect the type of
glomerular lesion produced. Evidence has been presented for
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selective deposition of certain IgG subgroups in both experi-
mental [23, 24] and human [21, 25] glomerular disease. In a
previous study, we reported a marked increase in glomerular
deposition of passively administered homologous cationic anti-
body compared to anionic antibody in the passive Heymann
nephritis model of membranous nephropathy in rats [24]. In
membranous nephropathy, antibody must penetrate much of
the capillary wall to reach the site of antigen localization and
deposit formation in the subepithelial space, and deposits
develop slowly over several days [261. In anti-GBM nephritis,
the nephritogenic antigen appears to reside more proximally in
the capillary wall [27—29] and deposit formation proceeds very
rapidly [30]. Nevertheless, negatively charged elements includ-
ing the sialoprotein coating of endothelial cells and perhaps
glycosaminoglycans in the lamina rara interna also lie between
the circulation and the site of anti-GBM antibody deposition [91.
We therefore carried out studies to determine the possible
effects of this charge barrier on the rate of deposition of
anti-GBM antibodies of varying electrical charge.
Methods
Preparation of anti-GBM antibodies
Sheep were immunized repeatedly with isolated whole rat
glomeruli until they developed high titers of anti-rat GBM
antibodies as detected by indirect immunofluorescence (IF)
[31]. Pilot studies demonstrated that 0.3 ml of antiserum admin-
istered intravenously to normal 250 g Sprague-Dawley rats
induced 4 + linear staining for sheep IgG on the GBM with no
extraglomerular deposits by IF, and urine protein excretion that
exceeded 20 mg/day (normal 5 mg) in the 24-hr period following
injection. A dose of 0.3 ml of sheep antiserum to rat GBM was
then injected into 63 normal rats. After 24 hr, 120 kidneys were
removed from 60 surviving rats. Within 24 hr of nephrectomy
the kidney cortices were isolated, chopped into small pieces,
and homogenized for 15 sec in a blender (Waring). The
homogenate was eluted with 0.02 M citrate buffer, pH 3.2, at
25°C for 4 hr followed by further elution at pH 2.5 for another
4 hr [32]. The eluted antibodies were separated from the
cortices by centrifugation, neutralized to pH 7.4 and concen-
trated. The eluate was characterized by immunoelectrophoresis
in 1% agarose gel using monospecific rabbit anti-sheep IgG
(N.L. Cappell Laboratories, Inc., Cochranville, Pennsylvania).
Indirect IF of anti-GBM eluate on cryostat sections of normal
rat kidney was also performed (see below). Twenty-four hours
after a normal rat was injected with 3 mg of crude anti-GBM
eluate (approximately 1 mg IgG), renal tissue samples were
examined with direct IF for sheep IgG.
Sheep IgG was isolated from anti-GBM eluate by ion ex-
change chromatography on DEAE Sephadex (Pharmacia Fine
Chemicals, Inc., Piscataway, New Jersey) [33], The cationic
IgG fraction was obtained with 0.01 M sodium phosphate
starting buffer, and the anionic IgG fraction was eluted follow-
ing application of a linear sodium chloride gradient to 0.2 M.
Each fraction was pooled separately, dialyzed against PBS, and
concentrated by ultrafiltration to approximately 2 mg/ml. The
isoelectric points of each reagent were determined by gel
isoelectric focusing using a thin-layer polyacrylamide gel (5%)
containing ampholytes with a pH range of 3.5 to 9.5 (Biorad
Laboratories, Richmond, California) and a horizontal
electrophoresis cell (Biorad Laboratories). The pH gradient
was determined directly from the gel with a surface glass pH
electrode and Corning pH meter (Corning Scientific Instru-
ments, Chicago, Illinois).
The content of glomerular deposit forming antibody in each
eluate fraction was determined in vitro by repeated absorptions
with isolated normal glomeruli [26]. Either 1.5 mg of 1251
cationic anti-GBM or 1.5 mg of 1251anionic anti-GBM IgG were
added to six tubes containing exactly 1.5 mg of lyophylized
glomeruli. The total volume of each tube was adjusted to 1 ml
with the addition of Hank's balanced salt solution (pH 7.4)
containing 2% bovine serum albumin, penicillin (500 U/dl) and
streptomycin (500 g/dl). The suspensions were mixed thor-
oughly and incubated at 37°C for 21 hr. The glomeruli were
separated by centrifugation at 2000 rpm for 15 mm and washed
with 100 l of modified Hank's solution. After the supernatant
and the wash were combined and added to another 1.5 mg of
lyophylized glomeruli, the mixture was adjusted to 1.0 ml with
modified Hank's solution, thoroughly mixed, and the suspen-
sion was again incubated at 37°C for 21 hr. Following seven
similar absorptions, protein-bound radioactivity in the superna-
tants was measured by precipitation with 10% trichloroacetic
acid. The fraction of antibody bound to glomeruli was calcu-
lated from the amount added initially minus the quantity re-
maining in the final supernatant; the results are expressed as a
percentage of the initial amount added.
Kinetics of anti-GBM IgG disappearance from blood and
deposition in glomeruli
After the administration of anti-GBM eluate IgG to rats, the
disappearance of antibodies from blood and the accumulation of
antibody in glomeruli were studied at intervals over a 2-day
period [26, 32]. Eighteen rats were each injected with 300
i.v. of radiolabelled anti-GBM eluate IgG containing equal
amounts of cationic and anionic fractions. Three rats were
sacrificed at intervals of 10 mm, 30 mm, 1, 4, 24, and 48 hr after
antibody administration for quantitative determinations of anti-
body deposition in glomeruli. At each time interval 100 l of
blood were obtained from every surviving animal for the
determination of blood IgG concentration. Blood samples were
taken at 6 hr instead of 4 hr in the three rats sacrificed at 48 hr.
The initial blood concentration of IgG for each animal was
calculated by dividing the administered dose of IgG by the rat's
blood volume (estimated at 7% body wt) [341.
A detailed account of the methods used to measure the
quantity of antibody specifically bound in glomeruli has been
published [26, 32]. In the present study, glomerular antibody
binding in each animal was calculated from the radioactivity of
glomeruli isolated from saline-perfused kidneys obtained just
prior to sacrifice and from the number of glomeruli isolated
from each pair of kidneys. The following equation was used:
glomerular antibody binding (tg/2 kidneys) =
cpm in glomeruli x 76,000 where 76,000
number of glomeruli x sp act of antibody
represents the number of glomeruli in two rat kidneys [35, 36].
Effect of antibody charge on glomerular antibody binding
The capacity of the cationic anti-GBM IgG fraction to bind to
glomeruli in vivo was compared to that of the anionic IgG
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fraction. Cationic antibodies were labelled with 131j and anionic
antibodies with 125J Since in vitro binding studies demonstrated
equal antibody content in the two fractions (see Results), equal
quantities of each were mixed together to form a solution
containing 141 /Lg/ml of '311-labelied cationic IgG and 143 j.tg/ml
of 1251-labelled anionic IgG. Incremental doses of this mixture
from 0.1 to 1.0 mliv. were administered to ten Sprague-Dawley
rats. At 15-mm intervals 100 l of blood were taken from the tail
of each animal for measurement of the concentration of cationic
and anionic IgG. At 1 hr glomerular antibody binding was
determined from glomeruli isolated from saline-perfused kid-
neys of each rat as described above. The initial blood concen-
tration of cationic and anionic IgG for each animal was calcu-
lated by dividing the administered dose of IgG by the rats blood
volume (estimated at 7% body wt) [34].
Delivery of antibody (Lg over a 1-hr study period) was
calculated by multiplying RBF times the area under the curve
found by plotting the blood concentration versus time. RBF
was assumed to be 5.4 mi/mm/kidney [37]. It was assumed that
the trace doses of antibody used in the study did not affect RBF.
Tissue processing and immunofluorescence microscopy
Renal tissue samples were obtained by wedge biopsy under
ether anesthesia and snap-frozen in dry ice-isopentane. Cryo-
stat sections fixed in ether-ethanol were stained using tech-
niques and controls described elsewhere [26, 381. The fluores-
cein isothiocyanate conjugated IgG fraction of monospecific
rabbit anti-sheep IgG (Cappel Laboratories, Inc., Cochranville,
Pennsylvania) was used for IF staining. IF was evaluated on a
fluorescence microscope equipped with a Ploempak 2.2vertical
fluorescence illuminator (Leitz Ortho!ux II, E. Leitz, Inc.,
Rockleigh, New Jersey).
Statistical analysis
The Student's r test for paired data was used to analyze the
results of in vitro glomerular binding of cationic and anionic IgG
fractions. Regression analysis and determination of the correla-
tion coefficient for data relating glomerular-bound antibody to
antibody concentration or antibody delivery were determined
by standard methods [39]. The slopes and elevation of the
regression lines generated were compared by the method of
least squares and analysis of covariance 139]. Differences were
regarded as significant when P < 0.05. All values are expressed
as mean 1 SD unless otherwise stated.
Other procedures
A detailed description of the methods used to radiolabel
antibodies has been described previously [26]. Briefly, eluate
fractions were radiodinated with either 125j or 1311 using the
chloramine-T method as modified by McConahey and Dixon
[40]. Specific activity of the individual reagents ranged from 1.8
x jo4 to 6.1 x j4 cpm/sg protein of which 69 to 88% was TCA
precipitable. All radioactive measurements were corrected for
background, decay, and spillover of 311 into the 251 channel.
Protein concentration of IgG purified from anti-GBM eluate
was measured by ultraviolet absorption at 280 nm using an
extinction coefficient of 1.4. Purified sheep IgG was measured
using the biuret method.
Fig. 1. Kidney biopsy specimen from a rat 24 hr after administration of
3 mg anti-GBM c/nate. Direct IF of linear deposits of sheep IgG is
demonstrated in a diffuse pattern along the glomerular capillary wall.
(x 400)
Results
Characterization of the anti-GBM c/nate
Elution of 120 kidneys, from rats that received 0.3 ml of
sheep antiserum to rat GBM, yielded approximately 40 mg of
sheep IgG. By immunoelectrophoresis sheep IgG was the only
serum protein identifiable in the eluate. Indirect IF of anti-GBM
eluate on cryostat sections of normal rat kidney demonstrated
intensely positive fluorescence of sheep IgG in a linear pattern
along the GBM, with less intense linear binding along the
tubular basement membranes. At I mg/mi of eluate IgG, the
indirect IF titer on GBM was 1: 100. Renal biopsy, performed 24
hr after intravenous administration of 1 mg of anti-GBM eluate
IgG to a normal rat, demonstrated 2—3 + sheep IgG in a diffuse
linear pattern along the GBM (Fig. 1). There were no other
glomerular deposits, and there was no extraglomerular sheep
IgG observed.
Isoelectric focusing of the eluate IgG fractions isolated by ion
exchange chromatography, demonstrated that pregradient anti-
bodies had a p1 range of 6.4 to 8.5 (cationic) and those obtained
postgradient had a p1 range of 4.2 to 6.8 (anionic). After seven
incubations with equal amounts of normal rat glomeruli, the
percentages of the cationic and anionic eluate IgG fractions
bound in vitro were not significantly different from each other
(cationic IgG = 69.6% 4.0, anionic IgG = 72.1% 2.4; P>
0.05).
Kinetics
The disappearance kinetics of anti-GBM eluate IgG from the
blood of rats that received 300 ig of a radiolabelled mixture
containing equal quantities of 1251 cationic and 125J anionic
antibodies are shown in Figure 2. Initially, there was a rapid
decline in blood concentration with 21.9% of the calculated
initial level remaining at 1 hr, which was followed by a more
gradual decline in blood concentration until only 1% of the
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antibody administered was still present in the circulation at 48
hr.
The kinetics of glomerular antibody deposition are also
illustrated in Figure 2. The maximal level of anti-GBM deposi-
tion occurred within 10 mm of administration of anti-GBM
eluate IgG. This was followed by an abrupt decline in glomer-
ular antibody binding with only 16% of the maximal antibody
deposited at 10 mm still present at 48 hr. This rise and fall in
glomerular antibody binding parallelled the rapid increase and
subsequent decrease observed in blood concentration.
Ejfrct of anti-GBM antibody charge on glomerular binding
in vivo
In rats given incremental doses of a mixture containing equal
concentrations of cationic and anionic anti-GBM antibodies,
there was a highly significant direct relationship between
glomerular-bound antibody and the blood concentration of
antibody at 1 hr (cationic antibody: r = 0.95, P <0.01; anionic
antibody: r = 0.97, P < 0.01). Glomerular antibody binding was
also highly correlated with the delivery of each antibody over
the 1-hr study period (cationic antibody: r = 0.98, P < 0.01;
anionic antibody: r = 0.98, P < 0.01; Fig. 3). The blood
concentration and delivery of cationic antibody at 1 hr was
lower than that of anionic antibody despite administration of an
equal dose due to more rapid removal of cationic antibody from
the vascular space. This increased disappearance of cationic
antibody could not be accounted for entirely by enhanced
glomerular binding. Although the blood concentration and
delivery of cationic antibody were lower than that of anionic
antibody, the quantity of cationic antibody deposited in
glomeruli was significantly greater than that of anionic anti-
body. This is demonstrated by the significantly greater slope of
the cationic line in Figure 3 (P < 0.001). which relates glomer-
I I I I
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Fig. 3. Relationship of glomerular antibody binding and delivery of
antibody at I hr after injecting rats with incremental doses of a mixture
containing equal quantities of cationic and anionic anti-GBM eluate
IgG. Each point represents the results obtained from a single rat. The
slope of the cationic line is significantly greater than the slope of the
anionic line (P < 0.001).
ular binding of each antibody preparation to its blood concen-
tration at 1 hr. Glomerular antibody binding of cationic anti-
body exceeded anionic antibody by three- to fourfold in each of
the ten animals, despite the finding that its blood concentration
at 1 hr was only 44 to 56% and its delivery was 80 to 85% that
of anionic antibody.
Discussion
It was formerly believed that the glomerulus served only as a
passive filter, or target, for various circulating immune re-
actants which deposited in it to cause tissue injury and glomeru-
lonephritis. It has now been clearly shown that alterations in
properties of the glomerulus itself substantially affect deposi-
tion of immune reactants. Thus, capillary wall injury induced
with aminonucleoside of puromycin or nephrotoxic serum
markedly reduces in situ deposit formation due to a fixed
subepithelial antigen 141, 42], but increases mesangial localiza-
tion of performed immune complexes [43, 441. Nephrotoxic
serum increases glomerular immune complex deposition in
acute serum sickness [45]. The glomerular property best doc-
umented to affect the process of immune deposit formation is
glomerular charge. Thus, a variety of cationic antigens have
been shown to localize in the capillary wall on a charge basis to
initiate local immune complex formation [15—17]. Rabbits im-
munized with cationic BSA develop capillary wall deposits and
proteinuria while animals immunized with anionic BSA do not,
despite equivalent amounts of circulating immune complexes
[171. Neutralization of negative charge with polycations reduces
cationic antigen localization and subsequent immune deposit
formation [19], but enhances deposit formation induced with
anionic antigen [20].
Despite the increasing recognition of the importance of
glomerular charge in the localization of various circulating
antigens in in situ immune complex formation, little attention
has been given to the possible effects of the charge barrier on
glomerular localization of antibody. In a previous study, we
showed that circulating cationic rat antibody to a fixed glomer-
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Fig. 2. The disappearance kinetics o.f 125J anti-GBM eluate IgG from
the blood of rats and simultaneous accumulation of antibody IgG in
glomeruli after intravenous administration of 300 g of anti-GBM
c/nate IgG.
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ular antigen localized on the subepithelial aspect of the capillary
wall much more readily than anionic antibody of the same size
and specificity [24]. This finding suggested that glomerular
charge properties may facilitate the selective deposition of IgG
antibodies of restricted subclasses with more cationic pis, a
phenomenon which could have substantial effects on the bio-
logic properties of the immune deposits formed in glomerular
disease and, consequently, on the tissue injury which results.
We therefore studied the role of antibody charge on glomerular
deposition of anti-GBM antibody, a disease in which restricted
subgroup deposition has been reported in humans [21, 25].
In this study, sheep anti-rat GBM antibody IgG was prepared
by eluting deposited sheep IgG antibody from the glomeruli of
rats injected with sheep anti-rat nephrotoxic serum, thereby
utilizing the glomerulus itself as an in vivo immunoabsorbent.
Following purification and separation, the presence of equiva-
lent amounts of deposit-forming antibody in the cationic and
anionic fractions of eluted IgG were then ascertained by in vitro
binding studies. As in previous studies of antibody binding to a
fixed glomerular antigen [24], following administration of anti-
GBM eluate IgG, a highly significant correlation was demon-
strated between glomerular antibody binding at 1 hr and both
serum levels of antibody at the end of 1 hr and total renal
delivery of antibody during the 1-hr period. This correlation
was equally strong for both cationic and anionic antibody
fractions. Cationic antibody disappeared from the circulation
more rapidly than anionic antibody resulting in blood levels at I
hr that were 44 to 56% lower than anionic antibody levels, and
total renal delivery that was 15 to 20% lower. This could not be
accounted for by IgG deposition in glomeruli. Despite reduced
blood levels and renal delivery, however, cationic antibody
binding in glomeruli exceeded that of anionic antibody by a
factor of at least three.
We believe the enhanced glomerular binding of cationic
anti-GBM antibody in vivo was probably not significantly
related to a nonspecific affinity of cationic IgG for glomerular
anionic sites. Gallo, Caulin-Glaser, and Lamm [161 demon-
strated capillary wall localization only of cationized, non-
antibody bovine gamma globulin but not of unmodified cationic
bovine gamma globulin (injected in immune complex form) [16].
Agadoa, Gauthier, and Mannik [46] have induced in situ sub-
epithelial immune deposits by injecting cationized rabbit anti-
human serum albumin IgG followed by the administration of
human serum albumin. In both of these studies, capillary wall
localization was achieved only after chemical modifications of
the IgG. Gallo et al [47] have also shown a tendency for animals
immunized with unmodified cationic IgG to develop subepithe-
hal deposits, although direct localization of the IgG antigen
alone was not documented. Nevertheless, the possibility exists
that some preferential localization of unmodified cationic IgG
may occur due to charge interactions with the capillary wall.
However, we feel this phenomenon is unlikely to have made a
significant contribution to our results. In previous studies we
have found that in vivo localization in rat glomeruli of normal
sheep IgG containing both cationic and anionic fractions rep-
resented only 0.025% of the injected material [261. This quantity
of nonspecific IgG localization, even if it came only from the
cationic fraction, would account for less than 12% of the
cationic antibody binding observed in this study and therefore
could not have contributed significantly to the results observed.
In addition, our paired-label studies of eluted rat antibody
containing both cationic and anionic fractions in the isolated
perfused rat kidney also demonstrated no nonspecific localiza-
tion of non-antibody IgG [32, 48].
Our findings, therefore, suggest that antibody access to the
relevant GBM antigen(s) is restricted by elements of the
glomerular charge barrier. This interpretation is consistent with
what is known of the relationship between the localization of
nephritogenic GBM antigens and other structural components
of the capillary wall. Although the biochemical composition of
the nephritogenic GBM antigen and its ultrastructural location
within the capillary wall have not been defined with precision,
most studies suggest that anti-GBM antibody localizes in the
basement membrane proper either in areas along its inner and
outer surface [27—29] or within the lamina densa itself [27, 49].
Thus, anti-GBM IgG must pass through fenestrae in the layer of
endothelial cells coated with polyanionic glycocalyx, and per-
haps also through portions of the lamina rara interna which
contains proteoglycans rich in polyanionic heparan sulfate [9].
Charge-selective properties of these proximal layers of the
glomerular filtration barrier have been demonstrated ultra-
structurally with molecules as large as IgG (55 A, molecular
weight 160,000) such as ferritin (61 A, molecular weight
400,000) [50, 51]. Thus, it seems likely that our results reflect
the fact that anionic IgG antibodies crossing the capillary wall
encounter functionally narrower pores due to charge repulsive
effects and are relatively restricted in their capacity to penetrate
to, and combine with, GBM antigen, as compared to cationic
antibodies of the same size and specificity.
A potential role of differences in antibody affinity between
cationic and anionic antibody fractions in producing the results
obtained cannot be totally excluded by our data. Because
nephritogenic GBM antigen is not available in pure form, no
meaningful measurements of antibody affinity can be made. The
elution procedure may select antibodies of lower affinity. How-
ever, previous observations have shown that cationic and
anionic antibody fractions are obtained simultaneously [24, 52],
and that fractionation of eluted anti-GBM IgG on the basis of
antibody affinity results in a similar distribution of IgG isoelec-
tric points in high and low affinity fractions [52]. In studies of
NZB mice, Ebling and Hahn [231 found a predominance of
cationic antibody in the renal eluate suggesting that if low
affinity antibodies were selected by the acid elution procedure,
they were predominantly cationic rather than anionic in nature.
Finally, in these studies, given sufficient time and access, both
antibody fractions bound equally well to glomeruli in vitro
suggesting that differences in affinity sufficient to affect in vivo
binding were minimal. A related issue is the possibility that a
negatively charged GBM antigen may elicit production of
antibodies of positive charge that exhibit greater affinity for the
antigen. Such a phenomenon, however, has been demonstrated
only in hapten-antigen antibody reactions in vitro [53, 54], and
the importance of this reciprocal charge effect in systems
involving antibody binding to large and heterogeneous tissue
antigens in vivo has not been established.
A second observation of interest in our studies was the
apparent direct relationship between antibody concentration in
blood and antibody bound in glomeruli. Maximal antibody
binding occurred within 10 mm as noted previously by other
investigators [30]. However, as circulating antibody levels fell,
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glomerular deposits diminished as well, suggesting a dynamic
equilibrium between circulating and deposited antibody. This
finding differs from the earlier studies of Unanue and Dixon [30]
which demonstrated a much slower decline in rat kidney
deposits of rabbit anti-rat kidney antibody. Several differences
between these studies probably account for this discrepancy.
First, antibody deposits in isolated glomeruli were measured in
our studies, whereas Unanue and Dixon measured whole
kidney deposits of antibody, a measurement that we [261 have
previously shown reflects a significant amount of nonglomerular
antibody deposits. Secondly, it is quite likely that the antiserum
use in earlier studies [30] contained antibodies to renal antigens
other than GBM, the kinetics of which differ from those
observed here [26, 321. Lastly, our results could reflect rapid
reversal of anti-GBM antibody binding due to low antibody
avidity or antibody damage induced by the elution procedure
itself.
In summary, these studies suggest an in vivo charge selective
effect on the deposition of antibody to GBM antigens similar to
that previously reported with antibody to a fixed subepithelial
antigen [24]. This effect favors cationic antibody deposition and
probably reflects a restricted access of anionic antibody to anti-
genic sites located within the capillary wall. The data further
demonstrate a previously unappreciated dynamic equilibrium be-
tween antibody deposited in the glomeruli and circulating anti-
GBM antibody. Both of these phenomena may be important
determinants of the amount and composition of anti-GBM anti-
body deposits in glomeruli, and therefore of the severity of tissue
injury produced.
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